CATH2 Peptide Delivery for Rapid Bovine Innate Immunity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Bovine animals face challenges in activating their innate immune memory, leading to a heightened vulnerability to infections due to the slow activation of adaptive immune responses, necessitating compositions and methods to induce or activate innate immune memory.
Innovation Solution
Administration of cathelicidin 2 (CATH2) peptide or its variants to bovines to activate or induce innate immune memory, using delivery methods such as intra-mammary delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If adaptive immune response is used to protect bovines from pathogens, then specific pathogen destruction is achieved, but the response time is too slow (at least a week)
Solution Approach 1:
The patent applies preliminary action by administering cathelicidin peptides to bovines before pathogen exposure to pre-activate innate immune cells. This creates a state of immune readiness where macrophages and other phagocytic cells are primed to respond immediately upon encountering pathogens, eliminating the typical one-week delay associated with adaptive immune activation. The peptide treatment establishes immune memory that enables rapid response without waiting for antigen-specific B and T cell development.
2Speed
If innate immune system is activated quickly to protect against pathogens, then rapid protection is achieved, but the immune memory remains inactivated in some bovines
Solution Approach 1:
The patent applies parameter changes by using cathelicidin peptides to modify the functional state of innate immune cells. The peptides alter key parameters including cell activation thresholds, cytokine production levels, and phagocytic activity. This biochemical parameter modification transforms the immune memory from an inactivated state to an activated state, enabling both rapid response speed and reliable immune memory functionality simultaneously.
3Reliability
If cathelicidin peptide is administered to activate innate immune memory, then rapid immune protection is achieved, but the complexity of peptide formulation and delivery increases
Solution Approach 1:
The patent applies the intermediary principle by using cathelicidin peptides as mediator molecules that bridge the gap between pathogen exposure and immune activation. These peptides serve as intermediate agents that directly interact with and activate innate immune cells through pattern recognition receptors. This intermediary approach simplifies the overall system by replacing complex adaptive immune mechanisms with a more straightforward peptide-mediated activation pathway, reducing delivery system complexity while maintaining reliable immune memory activation.
Data Source
AI summary
The invention relates to compositions and methods for activating innate immunity. Specifically, the invention relates to cathelicidin peptides for activating or inducing innate immunity.